Skip to main content

Advertisement

Table 5 Survival analysis on all case by Log-rank analysis (n = 121)

From: Expressions and clinical significances of c-MET, p-MET and E2f-1 in human gastric carcinoma

Parameters Grouping Case number (n/%) χ2value df P value
Tumor diameter (cm) <5 48/(39.7) 9.190 1 0.002
≥5 73/(60.3)
Tumor location Cardia, fundus 20/(16.5) 8.122 2 0.017
Body 37/(30.6)
Pylorus, antrum 64/(52.9)
Invasion depth T1 18/(14.9) 11.712 3 0.008
T2 32/(26.4)
T3 30/(24.8)
T4 41/(33.9)
Involving lymph node station N0 43/(35.5) 24.017 3 <0.001
N1 41/(33.9)
N2 26/(21.5)
N3 11/(9.1)
Metastatic lymph node ratio <35% 60/(49.6) 8.596 1 0.003
≥35% 61/(50.4)
TNM stage Ia 16/(13.2) 25.405 5 <0.001
Ib 17/(14.0)
II 20/(16.5)
IIIa 20/(16.5)
IIIb 22/(18.2)
IV 26/(21.5)
c-MET expression Positive 80/(66.1) 12.084 1 0.001
Negative 41/(33.9)
p-MET expression Positive 72(59.5) 5.687 1 <0.001
Negative 49(40.5)
e2f-1 expression Positive 47/(38.8) 3.217 1 0.036
Negative 74/(61.2)
Ki-67 expression Positive 88/(72.7) 9.348 1 0.002
Negative 33/(27.3)